Ferroptosis, a form of controlled cell death, has received enormous media attention for its causal influence on the development and progression of chronic illnesses such as cancer. In contrast to apoptosis, ferroptosis causes iron-dependent peroxidation
of lipids and death. More recently, ferroptosis has been shown to inhibit tumor growth and make many cancers more susceptible to chemotherapy and immunotherapy. That makes ferroptosis a promising candidate for novel cancer
treatments. At Creative Biolabs, we have developed a comprehensive tumor ferroptosis analysis platform to assist in the identification and development of novel ferroptosis therapeutic approaches.
Our platform is built to rationally seek and test novel ferroptosis targets, discover how they work, and learn how they might work in combination with other cancer therapies.
Fig.1 Molecular basis of ferroptosis and strategies for therapeutic induction of ferroptosis.1